Author | Michael Brawer, MD | OncLive

Author | Michael Brawer, MD

Articles

Dr. Brawer on the Results of the Prolaris Test for Patients Prostate Cancer

September 06, 2017

Video

Michael Brawer, MD, vice president of medical affairs, Myriad Genetic Laboratories, discusses the results of the Prolaris genetic test in predicting prostate cancer aggressiveness in African-American men.

Dr. Brawer on the Significance of the Prolaris Genetic Test for Prostate

August 17, 2017

Video

Michael Brawer, MD, vice president of medical affairs, Myriad Genetic Laboratories, discusses the significance of the Prolaris genetic test in predicting prostate cancer aggressiveness in African-American men.

Dr. Brawer on the Prolaris Genetic Test in Predicting Prostate Cancer Aggressiveness

May 22, 2017

Video

Michael Brawer, MD, vice president of Medical Affairs, Myriad Genetic Laboratories, discusses the Prolaris genetic test in predicting prostate cancer aggressiveness in African-American men.

Dr. Brawer on Clinical Utility of CCP Test in Prostate Cancer

May 17, 2015

Video

Michael Brawer, MD, vice president of Medical Affairs, Myriad Genetic Laboratories, discusses the clinical utility of the cell cycle progression (CCP) test in personalizing prostate cancer treatment.

x